SCHEMBL3219783

SCHEMBL3219783

Cc1c(S(=O)(=O)N2CCN(c3cccc(F)c3)CC2)sc2ccc(Cl)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.54
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
THRB P10828 1/20 0.46
MAPT P10636 1/20 0.44
SMPD1 P17405 1/20 0.44
LMNA P02545 1/20 0.44
BCL2 P10415 1/20 0.44
BCL2L1 Q07817 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PTPN11 Q06124 1/20 0.43
PFKFB3 Q16875 1/20 0.43
PFKFB4 Q16877 1/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
HTR1D P28221 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207370 0.81 HTR6 (0.48) HTR6SMN1; SMN2LMNABCL2BCL2L1
SCHEMBL7028312 0.77 HTR6 (0.46) HTR6MEN1KMT2ANPSR1L3MBTL1
SCHEMBL3206006 0.76 HSD11B1 (0.64)
SCHEMBL13598936 0.75 HTR6 (0.58) HTR6NPSR1L3MBTL1PFKFB3PFKFB4
SCHEMBL3201889 0.74 HTR6 (0.55) HTR6NPSR1L3MBTL1PFKFB3PFKFB4
SCHEMBL6980951 0.73 HTR6 (0.80) HTR6NPSR1L3MBTL1HTR1ADRD2
SCHEMBL13987535 0.72 ALDH1A1 (0.48) HTR6MEN1KMT2AMAPTLMNA
SCHEMBL5271582 0.72 ALDH1A1 (0.48) HTR6MEN1KMT2AMAPTLMNA
SCHEMBL18047064 0.72 HTR6 (0.53) HTR6PFKFB3PFKFB4HTR1ADRD2
SCHEMBL29608319 0.72 HTR6 (0.53) HTR6PFKFB3PFKFB4HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 HTR6 2021/4885MEN1 1354/4885KMT2A 1609/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 HTR6 1213/4885MEN1 1687/4885KMT2A 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.